Monday, 14 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14389
Articles
Company
Deals
Luye Pharma’s Subsidiary Boan Biotech Partners with Haier Biomedical for Pharmaceutical Industry Digitalization
October 13, 2024
Company
Deals
Signet Therapeutics and Jennio Biotech Join Forces to Advance Tumor Immunotherapy
October 13, 2024
Policy / Regulatory
China Aims to Fortify Insurance Industry by 2035 with New State Council Directives
October 13, 2024
Company
Drug
Suzhou GenAssist Launches First-of-Its-Kind Base Editing Drug Trial for Duchenne Muscular Dystrophy
October 13, 2024
Company
Medical Device
Siemens Healthineers’ 7T MRI System Terra. X Receives NMPA Marketing Approval
October 10, 2024
Company
Drug
Innovent Biologics’ Mazdutide Outperforms Dulaglutide in Phase III T2D Study at EASD Meeting
October 13, 2024
Company
Deals
CSA Medical Inc. Secures USD 53 Million in Series D Financing to Advance Cryotherapy Treatment
October 13, 2024
Company
Celltrion Inc. Enters CDMO Arena Amid Shifts in Global Biosecurity Landscape
October 13, 2024
Company
Deals
Gilead Sciences Partners with AI Firm Genesis Therapeutics to Develop Novel Small-Molecule Therapies
October 13, 2024
Company
Deals
Carisma Therapeutics and Moderna Expand Partnership to Target Autoimmune Diseases with CAR-M Therapies
October 13, 2024
Company
Deals
Itcure Expands Gene Editing Reach with Collaborations in China’s Biotech Sector
October 13, 2024
Company
Drug
Qilu Pharmaceutical’s Iruplinalkib Shows Promising Results in Phase II Study for ALK+ NSCLC
October 13, 2024
1
2
…
587
588
589
590
591
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?